サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：消化管治療薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年予測
市場調査レポート
商品コード
1305288

消化管治療薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年予測

Global Gastrointestinal Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 350 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
消化管治療薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年予測
出版日: 2023年06月01日
発行: Value Market Research
ページ情報: 英文 350 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

消化管治療薬市場の世界需要は、調査期間2023～2030年のCAGR6.42%で、2022年の488億6,000万米ドルから2030年には803億8,000万米ドル近くの市場規模に達すると推定されます。

消化管治療薬は、結腸、小腸、大腸、直腸に影響を及ぼす消化器系の問題である胃腸障害を治療します。この消化管の慢性炎症性疾患は主に結腸粘膜に影響を及ぼします。便秘、消化性潰瘍疾患、過敏性腸症候群が最も一般的な疾患で、不快感、腹部膨満感、下痢、吐き気、嘔吐などの症状があります。消化管治療薬には、アシフェックス、アフィニトール、アキンゼオ、ディフェット、プリロセックなどの市販薬があります。

市場力学：

消化器疾患の有病率の増加は、より良いヘルスケアへのアクセスを強化し、ライフスタイルを変え、工業化と衛生化率を高めるために、消化管治療薬に対する需要も高めており、市場の成長を増加させると思われます。数多くの研究開発機関が新しい治療法を研究しており、消化管治療薬の市場拡大を後押しすると予想されます。消化管治療薬の市場は、信頼性の高い結果を伴う臨床研究の増加やヘルスケア支出の増加により拡大しています。高齢化社会は拡大しており、高齢者はこのような健康上の問題を抱えやすいため、市場拡大が加速すると思われます。しかし、消化管治療薬の市場拡大は、治療薬や投薬の関連する副作用や、医薬品承認のための政府の厳しい制限によって妨げられる可能性があります。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、消化管治療薬の世界市場における各セグメントを包括的に評価することもできます。消化管治療薬業界の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション：

消化管治療薬市場レポートのこのセクションでは、国レベルおよび地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家が今後の機会とともに、それぞれの製品やサービスのターゲット層を特定するのに役立ちます。

タイプ別

  • ブランド品
  • ジェネリック

薬剤クラス別

  • アミノサリチル酸塩
  • 消化酵素
  • プロトンポンプ阻害薬
  • 緩下剤
  • 抗化粧品
  • H2拮抗薬
  • 下痢止め
  • 生物製剤/バイオシミラー
  • その他

投与経路別

  • 経口
  • 注射剤
  • その他

用途別

  • クローン病
  • 潰瘍性大腸炎
  • 胃腸炎
  • 過敏性腸症候群
  • その他

流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンライン薬局

地域別分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおける消化管治療薬市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 消化管治療薬- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 消化管治療薬の世界市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • ブランド
  • ジェネリック医薬品

第7章 消化管治療薬の世界市場分析：薬剤クラス別

  • 薬剤クラス別概要
  • 実績データと予測データ
  • 薬剤クラス別分析
  • アミノサリチル酸塩
  • 消化酵素薬
  • プロトンポンプ阻害薬
  • 緩下剤
  • 抗化粧品
  • H2拮抗薬
  • 下痢止め
  • 生物製剤/バイオシミラー
  • その他

第8章 消化管治療薬の世界市場分析：投与経路別

  • 投与経路別概要
  • 実績データと予測データ
  • 投与経路別分析
  • 経口剤
  • 注射剤
  • その他

第9章 消化管治療薬の世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • クローン病
  • 潰瘍性大腸炎
  • 胃食道逆流症
  • 過敏性腸症候群
  • その他

第10章 消化管治療薬の世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第11章 消化管治療薬の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績および予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績および予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績および予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績および予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績および予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第12章 消化管治療薬企業の競合情勢

  • 消化管治療薬市場競争
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第13章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • AbbVie Inc.
  • AstraZeneca
  • Janssen Pharmaceuticals NV
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Salix Pharmaceuticals
  • Pfizer Inc.
  • Bayer AG
  • Abbott
  • Cipla Inc.
  • Gilead Sciences Inc.
  • Biogen
  • Organon Group of Companies

注-企業プロファイルにおいて、財務の詳細や最近の動向は、入手可能な情報に基づいているか、非公開会社の場合はカバーしていない可能性があります。

図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Branded Market Sales by Geography (USD MN)
  • Generics Market Sales by Geography (USD MN)
  • Analysis Market by Drug Class (USD MN)
  • Aminosalicylates Market Sales by Geography (USD MN)
  • Digestive Enzymes Market Sales by Geography (USD MN)
  • Proton Pump Inhibitors Market Sales by Geography (USD MN)
  • Laxatives Market Sales by Geography (USD MN)
  • Anti-Emetics Market Sales by Geography (USD MN)
  • H2 Antagonists Market Sales by Geography (USD MN)
  • Anti-Diarrheal Market Sales by Geography (USD MN)
  • Biologics/Biosimilar Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Injectable Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Crohn's Disease Market Sales by Geography (USD MN)
  • Ulcerative Colitis Market Sales by Geography (USD MN)
  • GERD Market Sales by Geography (USD MN)
  • IBS Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Gastrointestinal Therapeutics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Gastrointestinal Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Gastrointestinal Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Drug Class
  • Market Attractiveness Analysis by Route Of Administration
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Branded Market Sales by Geography (USD MN)
  • Generics Market Sales by Geography (USD MN)
  • Global Market Analysis by Drug Class (USD MN)
  • Aminosalicylates Market Sales by Geography (USD MN)
  • Digestive Enzymes Market Sales by Geography (USD MN)
  • Proton Pump Inhibitors Market Sales by Geography (USD MN)
  • Laxatives Market Sales by Geography (USD MN)
  • Anti-Emetics Market Sales by Geography (USD MN)
  • H2 Antagonists Market Sales by Geography (USD MN)
  • Anti-Diarrheal Market Sales by Geography (USD MN)
  • Biologics/Biosimilar Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Injectable Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Crohn's Disease Market Sales by Geography (USD MN)
  • Ulcerative Colitis Market Sales by Geography (USD MN)
  • GERD Market Sales by Geography (USD MN)
  • IBS Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112110049

The global demand for Gastrointestinal Therapeutics Market is presumed to reach the market size of nearly USD 80.38 BN by 2030 from USD 48.86 BN in 2022 with a CAGR of 6.42% under the study period 2023 - 2030.

Gastrointestinal therapeutics treats gastrointestinal disorders, which are digestive system issues affecting the colon, small and large intestines, and rectum. This chronic inflammatory illness of the gastrointestinal tract mainly affects the colon's mucosal lining. Constipation, peptic ulcer diseases, and irritable bowel syndrome are the most common conditions, with symptoms such as discomfort, bloating, diarrhoea, nausea, and vomiting. Gastrointestinal therapeutics include commercially accessible medication such as Aciphex, Afinitor, akynzeo, deficit, and Prilosec.

Market Dynamics:

The rising prevalence of gastrointestinal disorders is also raising demand for gastrointestinal therapeutics to enhance better healthcare access, to change lifestyles, and for higher rates of industrialization and sanitation, which will increase the market growth. Numerous R&D organizations are investigating new therapeutic modalities, which are anticipated to boost the market expansion of gastrointestinal therapeutics. The market for gastrointestinal therapeutics is expanding due to more clinical studies with reliable outcomes and rising healthcare expenditure. The ageing population is growing, which will accelerate market expansion because they are more prone to such health problems. However, the market expansion of gastrointestinal therapeutics can be hampered by related side effects of therapies and medication and strict governmental restrictions for drug approval.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gastrointestinal therapeutics. The growth and trends of gastrointestinal therapeutics industry provide a holistic approach to this study.

Market Segmentation:

This section of the gastrointestinal therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Branded
  • Generics

By Drug Class

  • Aminosalicylates
  • Digestive Enzymes
  • Proton Pump Inhibitors
  • Laxatives
  • Anti-Emetics
  • H2 Antagonists
  • Anti-Diarrheal
  • Biologics/Biosimilar
  • Others

By Route Of Administration

  • Oral
  • Injectable
  • Others

By Application

  • Crohn'S Disease
  • Ulcerative Colitis
  • Gerd
  • IBS
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Gastrointestinal Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gastrointestinal therapeutics market include AbbVie Inc., AstraZeneca, Janssen Pharmaceuticals NV, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Salix Pharmaceuticals, Pfizer Inc., Bayer AG, Abbott, Cipla Inc., Gilead Sciences Inc., Biogen, Organon Group of Companies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . GASTROINTESTINAL THERAPEUTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Drug Class
    • 3.7.3 Market Attractiveness Analysis By Route Of Administration
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Branded Historic and Forecast Sales by Regions
  • 6.5 Generics Historic and Forecast Sales by Regions

7 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

  • 7.1 Overview by Drug Class
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Drug Class
  • 7.4 Aminosalicylates Historic and Forecast Sales by Regions
  • 7.5 Digestive Enzymes Historic and Forecast Sales by Regions
  • 7.6 Proton Pump Inhibitors Historic and Forecast Sales by Regions
  • 7.7 Laxatives Historic and Forecast Sales by Regions
  • 7.8 Anti-Emetics Historic and Forecast Sales by Regions
  • 7.9 H2 Antagonists Historic and Forecast Sales by Regions
  • 7.10. Anti-Diarrheal Historic and Forecast Sales by Regions
  • 7.11 Biologics/Biosimilar Historic and Forecast Sales by Regions
  • 7.12 Others Historic and Forecast Sales by Regions

8 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 8.1 Overview by Route Of Administration
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Route Of Administration
  • 8.4 Oral Historic and Forecast Sales by Regions
  • 8.5 Injectable Historic and Forecast Sales by Regions
  • 8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Crohn's Disease Historic and Forecast Sales by Regions
  • 9.5 Ulcerative Colitis Historic and Forecast Sales by Regions
  • 9.6 GERD Historic and Forecast Sales by Regions
  • 9.7 IBS Historic and Forecast Sales by Regions
  • 9.8 Others Historic and Forecast Sales by Regions

10 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 10.1 Overview by Distribution Channel
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Distribution Channel
  • 10.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 10.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 10.6 Online Pharmacies Historic and Forecast Sales by Regions

11 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE GASTROINTESTINAL THERAPEUTICS COMPANIES

  • 12.1. Gastrointestinal Therapeutics Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF GASTROINTESTINAL THERAPEUTICS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. AbbVie Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. AstraZeneca
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Janssen Pharmaceuticals NV
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Sun Pharmaceutical Industries Ltd.
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Takeda Pharmaceutical Company Limited
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Salix Pharmaceuticals
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Pfizer Inc.
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Bayer AG
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Abbott
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Cipla Inc.
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. Gilead Sciences Inc.
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Biogen
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. Organon Group of Companies
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies